Siri H. Strand
Siri H. Strand
Research Engineer, Stanford University
Verified email at
Cited by
Cited by
The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution
Cell 181 (2), 236-249, 2020
Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma
T Risom, DR Glass, I Averbukh, CC Liu, A Baranski, A Kagel, ...
Cell 185 (2), 299-310. e18, 2022
Prognostic DNA methylation markers for prostate cancer
SH Strand, TF Orntoft, KD Sorensen
International journal of molecular sciences 15 (9), 16544-16576, 2014
Hypermethylation of the GABRE∼ miR-452∼ miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomy
H Kristensen, C Haldrup, S Strand, K Mundbjerg, MM Mortensen, ...
Clinical Cancer Research 20 (8), 2169-2181, 2014
Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer
KD Sørensen, MO Abildgaard, C Haldrup, BP Ulhøi, H Kristensen, ...
British journal of cancer 108 (2), 420-428, 2013
Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies
C Haldrup, AL Pedersen, N Øgaard, SH Strand, S Høyer, M Borre, ...
Molecular oncology 12 (4), 545-560, 2018
Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer
TM Storebjerg, SH Strand, S Høyer, AS Lynnerup, M Borre, TF Ørntoft, ...
Clinical epigenetics 10, 1-16, 2018
MITI minimum information guidelines for highly multiplexed tissue images
D Schapiro, C Yapp, A Sokolov, SM Reynolds, YA Chen, D Sudar, Y Xie, ...
Nature methods 19 (3), 262-267, 2022
HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer
H Ross-Adams, S Ball, K Lawrenson, S Halim, R Russell, C Wells, ...
Oncotarget 7 (46), 74734, 2016
Heterogeneous patterns of DNA methylation-based field effects in histologically normal prostate tissue from cancer patients
M Møller, SH Strand, K Mundbjerg, G Liang, I Gill, C Haldrup, M Borre, ...
Scientific reports 7 (1), 40636, 2017
High levels of 5-hydroxymethylcytosine (5hmC) is an adverse predictor of biochemical recurrence after prostatectomy in ERG-negative prostate cancer
SH Strand, S Hoyer, AS Lynnerup, C Haldrup, TM Storebjerg, M Borre, ...
Clinical epigenetics 7, 1-12, 2015
Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer
MT Bjerre, SH Strand, M Nørgaard, H Kristensen, AKI Rasmussen, ...
International journal of molecular sciences 20 (5), 1173, 2019
Training and validation of a novel 4-miRNA ratio model (MiCaP) for prediction of postoperative outcome in prostate cancer patients
L Schmidt, J Fredsøe, H Kristensen, SH Strand, A Rasmussen, S Høyer, ...
Annals of oncology 29 (9), 2003-2009, 2018
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts
SH Strand, B Rivero-Gutiérrez, KE Houlahan, JA Seoane, LM King, ...
Cancer cell 40 (12), 1521-1536. e7, 2022
FRMD6 has tumor suppressor functions in prostate cancer
J Haldrup, SH Strand, C Cieza-Borrella, ME Jakobsson, M Riedel, ...
Oncogene 40 (4), 763-776, 2021
Epigenetic analysis of circulating tumor DNA in localized and metastatic prostate cancer: evaluation of clinical biomarker potential
MT Bjerre, M Nørgaard, OH Larsen, SØ Jensen, SH Strand, P Østergren, ...
Cells 9 (6), 1362, 2020
RHCG and TCAF1 promoter hypermethylation predicts biochemical recurrence in prostate cancer patients treated by radical prostatectomy
SH Strand, M Switnicki, M Moller, C Haldrup, TM Storebjerg, J Hedegaard, ...
Oncotarget 8 (4), 5774, 2017
Elevated miR-615-3p expression predicts adverse clinical outcome and promotes proliferation and migration of prostate cancer cells
EB Laursen, J Fredsøe, L Schmidt, SH Strand, H Kristensen, ...
The American Journal of Pathology 189 (12), 2377-2388, 2019
A novel combined miRNA and methylation marker panel (miMe) for prediction of prostate cancer outcome after radical prostatectomy
SH Strand, E Bavafaye‐Haghighi, H Kristensen, AK Rasmussen, S Hoyer, ...
International Journal of Cancer 145 (12), 3445-3452, 2019
Exploring the transcriptome of hormone-naive multifocal prostate cancer and matched lymph node metastases
L Schmidt, M Møller, C Haldrup, SH Strand, S Vang, J Hedegaard, ...
British journal of cancer 119 (12), 1527-1537, 2018
The system can't perform the operation now. Try again later.
Articles 1–20